~ 29 ~ International Journal of Orthopaedics Sciences 2020; 6(1): 29-33 E-ISSN: 2395-1958 P-ISSN: 2706-6630 IJOS 2020; 6(1): 29-33 © 2020 IJOS www.orthopaper.com Received: 18-11-2019 Accepted: 22-12-2019 Sushanta Kumar Das. M Pharm Associate Professor and Coordinator, Department of Pharm D, Attached with Gandhi Medical College and Hospital, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India Dr. J Satyanarayana Professor and Head, Department of Orthopedics, Gandhi Medical College & Hospital, Secunderabad, Telangana, India Rabia Arshi Department of Pharm D, Attached with Gandhi Medical College & Hospital, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India Sangishetti Kaveri Department of Pharm D, Attached with Gandhi Medical College & Hospital, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India Sanjana Yadav Manuka Department of Pharm. D, Attached with Gandhi Medical College & Hospital, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India Shreya Varanasi Prasanna Department of Pharm. D, Attached with Gandhi Medical College & Hospital, CMR College of Pharmacy, Medchal, Hyderabad, Telangana, India Corresponding Author: Dr. J Satyanarayana Professor and Head, Department of Orthopedics, Gandhi Medical College & Hospital, Secunderabad, Telangana, India A prospective comparative study on analgesia effect between diclofenac sodium and tramadol hydrochloride used in various orthopedic trauma conditions by applying wong-baker faces pain rating scale in a tertiary care teaching hospital Sushanta Kumar Das M Pharm, Dr. J Satyanarayana, Rabia Arshi, Sangishetti Kaveri, Sanjana Yadav Manuka and Shreya Varanasi Prasanna DOI: https://doi.org/10.22271/ortho.2020.v6.i1a.1829 Abstract Acute pain in orthopedic trauma should be anticipated and treatment should be a part of every anesthetic plan. In this study we have aimed to assess the comparison of pain management effects between Diclofenac and Tramadol in orthopedic trauma condition along with Wong-Baker Faces Pain Rating Scale to demonstrate which drug provides better efficacy. This prospective case analysis study was conducted during August and September 2019 in the Department of Orthopedics, Gandhi Hospital, Secunderabad with necessary permission. Selected Cases were collected and documented. Outcome was framed after interpreting the data; according to various category and parameters. 30 cases were identified, included and observed in our study considering 15 each in Diclofenac and Tramadol respectively and analyzed for final outcome. Our study shows that male with age group of 21 – 40 yrs were predominant in developing orthopedic wound. In our study, we also found cases where both Tramadol and Diclofenac were prescription for the management of pain. Out of 15 patients prescribed with Tramadol, Wong-Baker score was found to be; for 4 patients ‘0’ (no hurt), 6 patients ‘2’ (hurts little bit), 4 patients ‘4’ (hurts little more) and only 1 patient ‘6’ (hurts even more) this shows that pain management with Tramadol was satisfactory. On the other hand, out of 15 cases prescribed with Diclofenac, Wong-Baker score was very less, as 6 cases had a score of ‘4’ (hurts little more), 5 cases had a score of ‘6’ (hurts even more), 4 cases had a score of ‘8’ (hurts whole lot). This indicates that Diclofenac may not be sufficient enough to manage orthopedic pain as compared to Tramadol, as orthopedic pain are acute and very complicated in nature; Tramadol may be the best choice to manage the pain. Keywords: Orthopedic trauma, diclofenac, tramadol, Wong-baker faces pain rating scale Introduction Acute pain in orthopedic trauma should be anticipated and treatment should be a part of every anesthetic plan. Analgesic approaches have changed in recent years in part due to patient expectations, the shift towards ambulatory surgery and shorter hospital stays. The classes of analgesics used to relieve pain in post-operative cases are non-steroidal anti-inflammatory drugs, local anesthetics, adrenergic agents and novel methods of applying opioid to conventional parenteral analgesics [1] . Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) of the phenyl acetic acid class with anti-inflammatory, analgesic, and antipyretic properties. Contrary to the action of many traditional NSAIDs, Diclofenac inhibits cyclooxygenase (COX)-2 enzymes with greater potency than it does COX-1. Similar to other NSAIDs, Diclofenac is associated with serious dose-dependent gastrointestinal, cardiovascular, and renal adverse effects. Since its introduction in 1973, a number of different Diclofenac-containing drug products have been developed with the goal of improving efficacy, tolerability, and patient convenience.